File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/IJG.0000000000000089
- Scopus: eid_2-s2.0-84924922034
- PMID: 25068466
- WOS: WOS:000346844000013
Supplementary
- Citations:
- Appears in Collections:
Article: Prospective study on the efficacy of treating normal tension glaucoma with a single session of selective laser trabeculoplasty
Title | Prospective study on the efficacy of treating normal tension glaucoma with a single session of selective laser trabeculoplasty |
---|---|
Authors | |
Keywords | Intraocular pressure Medication Normal tension glaucoma Selective laser trabeculoplasty |
Issue Date | 2015 |
Citation | Journal of glaucoma, 2015, v. 24, n. 1, p. 77-80 How to Cite? |
Abstract | PURPOSE: The purpose of this study was to investigate the efficacy of selective laser trabeculoplasty (SLT) in the treatment of normal tension glaucoma (NTG). METHODS: This prospective cohort study recruited consecutive cases of NTG on antiglaucoma medication. Cases were excluded for previous glaucoma surgery or laser. All patients underwent a 1-month washout of medication followed by a mean baseline intraocular pressure (IOP) measured at 9 AM, 1 PM, and 5 PM. A 30% reduction from baseline was set as the target IOP. A single session of SLT was performed to 360 degrees of the trabecular meshwork. IOP phasing was repeated at 1 month after SLT and medication was resumed to achieve the target IOP. Patients were followed up to 6 months after SLT. RESULTS: In 83 eyes of 46 subjects, the mean prestudy IOP was 14.2 ± 3.1 mm Hg when on 1.5 ± 0.9 antiglaucoma medication. The mean baseline IOP without medication was 16.1 ± 2.2 mm Hg. The mean SLT shots applied was 187.8 ± 27.5 using a mean energy of 1.0 ± 0.07 mJ. At 1-month post-SLT, the IOP was 12.7 ± 2.0 mm Hg (21.6% IOP reduction) from baseline without medication (P<0.05). The 6-month IOP was 11.4 ± 1.6 mm Hg when on 1.1± 1.0 medications, representing a 19.7% reduction from prestudy IOP, a 29.6% reduction from baseline IOP, and a 26.7% reduction in antiglaucoma medication (all P< 0.05). A higher baseline IOP was correlated with greater IOP reduction with SLT (r=0.3, P=0.009). CONCLUSIONS: A single session of SLT for NTG achieved an additional 20% reduction in IOP with 27% less medication at 6 months compared with prestudy levels while maintaining a 30% reduction from baseline IOP. |
Persistent Identifier | http://hdl.handle.net/10722/222172 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jacky W Y | - |
dc.contributor.author | Gangwani, Rita A. | - |
dc.contributor.author | Chan, Jonathan C H | - |
dc.contributor.author | Lai, Jimmy S M | - |
dc.date.accessioned | 2015-12-21T06:49:10Z | - |
dc.date.available | 2015-12-21T06:49:10Z | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | Journal of glaucoma, 2015, v. 24, n. 1, p. 77-80 | - |
dc.identifier.uri | http://hdl.handle.net/10722/222172 | - |
dc.description.abstract | PURPOSE: The purpose of this study was to investigate the efficacy of selective laser trabeculoplasty (SLT) in the treatment of normal tension glaucoma (NTG). METHODS: This prospective cohort study recruited consecutive cases of NTG on antiglaucoma medication. Cases were excluded for previous glaucoma surgery or laser. All patients underwent a 1-month washout of medication followed by a mean baseline intraocular pressure (IOP) measured at 9 AM, 1 PM, and 5 PM. A 30% reduction from baseline was set as the target IOP. A single session of SLT was performed to 360 degrees of the trabecular meshwork. IOP phasing was repeated at 1 month after SLT and medication was resumed to achieve the target IOP. Patients were followed up to 6 months after SLT. RESULTS: In 83 eyes of 46 subjects, the mean prestudy IOP was 14.2 ± 3.1 mm Hg when on 1.5 ± 0.9 antiglaucoma medication. The mean baseline IOP without medication was 16.1 ± 2.2 mm Hg. The mean SLT shots applied was 187.8 ± 27.5 using a mean energy of 1.0 ± 0.07 mJ. At 1-month post-SLT, the IOP was 12.7 ± 2.0 mm Hg (21.6% IOP reduction) from baseline without medication (P<0.05). The 6-month IOP was 11.4 ± 1.6 mm Hg when on 1.1± 1.0 medications, representing a 19.7% reduction from prestudy IOP, a 29.6% reduction from baseline IOP, and a 26.7% reduction in antiglaucoma medication (all P< 0.05). A higher baseline IOP was correlated with greater IOP reduction with SLT (r=0.3, P=0.009). CONCLUSIONS: A single session of SLT for NTG achieved an additional 20% reduction in IOP with 27% less medication at 6 months compared with prestudy levels while maintaining a 30% reduction from baseline IOP. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of glaucoma | - |
dc.subject | Intraocular pressure | - |
dc.subject | Medication | - |
dc.subject | Normal tension glaucoma | - |
dc.subject | Selective laser trabeculoplasty | - |
dc.title | Prospective study on the efficacy of treating normal tension glaucoma with a single session of selective laser trabeculoplasty | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1097/IJG.0000000000000089 | - |
dc.identifier.pmid | 25068466 | - |
dc.identifier.scopus | eid_2-s2.0-84924922034 | - |
dc.identifier.hkuros | 234667 | - |
dc.identifier.hkuros | 264617 | - |
dc.identifier.volume | 24 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 77 | - |
dc.identifier.epage | 80 | - |
dc.identifier.eissn | 1536-481X | - |
dc.identifier.isi | WOS:000346844000013 | - |
dc.identifier.issnl | 1057-0829 | - |